Global Psoriatic Arthritis Treatment Market Trends, Opportunities and Forecast 2020 – 2026

According to the Acumen Research and Consulting, the global Psoriatic Arthritis Treatment market is expected to reach at US$ 17.8 billion by 2026, along with the projected CAGR of 9.9 % from 2020-2026.

The published report global Psoriatic Arthritis Treatment market provides a holistic overview of the current market covering the current trends. The provided quantitative and qualitative data is based on the deeper analysis of the historical data and the current market situation that helps to provide an overview of the forecasted period.

Get Sample PDF @ https://www.acumenresearchandconsulting.com/request-sample/1514

The global Psoriatic Arthritis Treatment market report provides deeper insights on the factors driving the global market along with the factors that are responsible to hamper the growth. In addition, the report provides the opportunities in the global Psoriatic Arthritis Treatment market that would help the competitors to increase the profit share.

The global Psoriatic Arthritis Treatment market report provides the quantitative information of the target segment that is covered in the report along with the regional data comparison.

The report provides an overview value chain analysis, Porters Five analysis, and cost structure analysis gives an idea of the industrial outlook. The global Psoriatic Arthritis Treatment market report covers the data of the major geographical regions such as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In addition, the report also covers the country cross section providing deeper insights of the particular region.

The published global Psoriatic Arthritis Treatment market report provides information about the major players operating in the target market. The company profile section provides important information about the major players, along with the financial overview, product segment revenue, the geographical presence of the company. It also provides information related to business development activities by the players such as merger & acquisition, partnerships and agreements.

The global Psoriatic Arthritis Treatment market report also covers the products information that is offered by the particular players along with the specification. In addition, the player positioning based on their business strengths and product offerings which provides the competitive outlook of the industry.

Market participants

Bristol-Myers Squibb Corporation, AbbVie Inc., Amgen Inc., Bausch Health Companies Inc. ; Johnson & Johnson Services Inc., AstraZeneca plc, Celgene Corporation, Novartis International AG, and Pfizer Inc. University of Collaboration, Partnerships and Joint Ventures

Market segmentation

Global Psoriatic Arthritis Treatment Market, By Drug Class

  • DMARD
  • NSAIDs
  • Biologics
  • Others

Global Psoriatic Arthritis Treatment Market, By Product Type

  • OTC
  • Prescriptions

Global Psoriatic Arthritis Treatment Market, By Route of Administration

  • Oral
  • Topical
  • Injectable

Global Psoriatic Arthritis Treatment Market, By Geography

  • North America.
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa (MEA)

Table of content

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Psoriatic Arthritis Treatment
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Psoriatic Arthritis Treatment Market By Drug Class
1.2.2.1. Global Psoriatic Arthritis Treatment Market Revenue and Growth Rate Comparison By Drug Class (2015-2026)
1.2.2.2. Global Psoriatic Arthritis Treatment Market Revenue Share By Drug Class in 2017
1.2.2.3. DMARD
1.2.2.4. NSAIDs
1.2.2.5. Biologics
1.2.2.6. Others
1.2.3. Psoriatic Arthritis Treatment Market By Product Type
1.2.3.1. Global Psoriatic Arthritis Treatment Market Revenue and Growth Rate Comparison By Product Type (2015-2026)
1.2.3.2. OTC
1.2.3.3. Prescriptions
1.2.4. Psoriatic Arthritis Treatment Market By Route of Administration
1.2.4.1. Global Psoriatic Arthritis Treatment Market Revenue and Growth Rate Comparison By Route of Administration (2015-2026)
1.2.4.2. Oral
1.2.4.3. Topical
1.2.4.4. Injectable
1.2.5. Psoriatic Arthritis Treatment Market by Geography
1.2.5.1. Global Psoriatic Arthritis Treatment Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) Psoriatic Arthritis Treatment Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Psoriatic Arthritis Treatment Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Psoriatic Arthritis Treatment Major Manufacturers in 2017
3.3. R&D Status and Technology Drug Class of Global Psoriatic Arthritis Treatment Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Psoriatic Arthritis Treatment Major Manufacturers in 2017

CHAPTER 4. PSORIATIC ARTHRITIS TREATMENT MARKET BY DRUG CLASS

4.1. Global Psoriatic Arthritis Treatment Revenue By Drug Class
4.2. DMARD
4.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.3. NSAIDs
4.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.4. Biologics
4.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 5. PSORIATIC ARTHRITIS TREATMENT MARKET BY PRODUCT TYPE

5.1. Global Psoriatic Arthritis Treatment Revenue By Product Type
5.2. OTC
5.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
5.3. Prescriptions
5.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 6. PSORIATIC ARTHRITIS TREATMENT MARKET BY ROUTE OF ADMINISTRATION

6.1. Global Psoriatic Arthritis Treatment Revenue By Route of Administration
6.2. Oral
6.2.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.3. Topical
6.3.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)
6.4. Injectable
6.4.1. Market Revenue and Growth Rate, 2015 – 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 – 2026 ($Million)

CHAPTER 7. NORTH AMERICA PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

7.1. North America Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 – 2026 ($Million)
7.2. North America Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. Psoriatic Arthritis Treatment Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
7.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
7.3.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
7.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
7.4.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
7.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
7.5.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)

CHAPTER 8. EUROPE PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

8.1. Europe Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 – 2026 ($Million)
8.2. Europe Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
8.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.3.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
8.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.4.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
8.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.5.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
8.6.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.6.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
8.7.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
8.7.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

9.1. Asia-Pacific Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 – 2026 ($Million)
9.2. Asia-Pacific Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
9.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.3.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
9.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.4.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
9.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.5.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
9.6.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.6.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
9.7.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.7.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
9.8.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
9.8.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)

CHAPTER 10. LATIN AMERICA PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

10.1. Latin America Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 – 2026 ($Million)
10.2. Latin America Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
10.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
10.3.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
10.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
10.4.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
10.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
10.5.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)

CHAPTER 11. MIDDLE EAST PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

11.1. Middle East Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 – 2026 ($Million)
11.2. Middle East Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
11.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
11.3.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
11.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
11.4.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
11.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
11.5.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)

CHAPTER 12. AFRICA PSORIATIC ARTHRITIS TREATMENT MARKET BY COUNTRY

12.1. Africa Psoriatic Arthritis Treatment Market Revenue and Growth Rate, 2015 – 2026 ($Million)
12.2. Africa Psoriatic Arthritis Treatment Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
12.3.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
12.3.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
12.4.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
12.4.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Drug Class, 2015 – 2026 ($Million)
12.5.2. Market Revenue and Forecast By Product Type, 2015 – 2026 ($Million)
12.5.3. Market Revenue and Forecast By Route of Administration, 2015 – 2026 ($Million)

CHAPTER 13. COMPANY PROFILE

13.1. Bristol-Myers Squibb Corporation
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. AbbVie Inc.
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Amgen Inc.
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Bausch Health Companies Inc.
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Johnson & Johnson Services Inc.
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. AstraZeneca plc
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Celgene Corporation
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Novartis International AG
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Pfizer Inc
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Others
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies

CHAPTER 14. RESEARCH APPROACH

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

Buy this premium report @ https://www.acumenresearchandconsulting.com/buy-now/0/1514

Contact us:

Sheetal k

Email: sales@acumenresearchandconsulting.com

Phone: +14079154157 | +14089009135

Website: https://www.acumenresearchandconsulting.com